迪哲医药高管发布减持计划后,股价下跌超5%!公司回应:对长期发展充满信心

每日经济新闻
Sep 06

每经记者|章光日    每经编辑|吴永久       近日,迪哲医药4位高管发布减持计划。《每日经济新闻》记者(以下简称每经记者)注意到,迪哲医药此次拟减持的4位高管的年薪都不低于200万元,其中3位高管去年已经实施过一次减持计划。从今年8月至今,迪哲医药自愿披露多份利好公告,比如与阿斯利康签署授权许可协议于2026年8月31日正式生效。迪哲医药对每经记者表示,公司始终认为,上市公司股价的长期走势...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10